Page last updated: 2024-10-25

debrisoquin and Bronchitis

debrisoquin has been researched along with Bronchitis in 1 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.

Research Excerpts

ExcerptRelevanceReference
" Determination of debrisoquine oxidation phenotype was carried out in 119 healthy subjects, 135 patients with chronic bronchitis and 153 patients with lung cancer, all of Caucasian origin."3.68Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer. ( Barre, J; Bechtel, P; Brochard, P; Dalphin, JC; de Cremoux, H; Depierre, A; Duche, JC; Joanne, C; Tillement, JP, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duche, JC1
Joanne, C1
Barre, J1
de Cremoux, H1
Dalphin, JC1
Depierre, A1
Brochard, P1
Tillement, JP1
Bechtel, P1

Other Studies

1 other study available for debrisoquin and Bronchitis

ArticleYear
Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer.
    British journal of clinical pharmacology, 1991, Volume: 31, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Chronic Disease; Debrisoquin; Female; Humans; Lung Neopl

1991